NORTHERN TRUST CORP - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 29 filers reported holding VIRIOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,228
-33.0%
24,0350.0%0.00%
Q2 2023$33,168
+469.9%
24,035
+51.8%
0.00%
Q1 2023$5,820
+55.7%
15,8360.0%0.00%
Q4 2022$3,737
-37.7%
15,8360.0%0.00%
Q3 2022$6,000
-91.0%
15,8360.0%0.00%
Q2 2022$67,000
-1.5%
15,836
+4.8%
0.00%
Q1 2022$68,000
-11.7%
15,1170.0%0.00%
Q4 2021$77,00015,1170.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 80,590$29,6160.10%
Warberg Asset Management LLC 74,750$27,4710.01%
&PARTNERS 11,000$4,0430.00%
UBS Group AG 1,636$6000.00%
Cetera Investment Advisers 26,769$9,8380.00%
OSAIC HOLDINGS, INC. 40,421$14,8510.00%
WELLS FARGO & COMPANY/MN 119$440.00%
NORTHERN TRUST CORP 15,836$5,8200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 14,368$5,2800.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders